1Schwarz DS,Hutvagner G,Haley B,et al.Evidence that siRNAs function as guides,not primers,in the Drosophila and human RNAi pathways[J].Mol Cell,2002,10(3):537-548.
3Cerutti H.RNA interference:traveling in the cell and gaining functions[J].Trends Cenet,2003,19(1):39-46.
4Nykanen A,Haley B,Zamore PD.ATP requirements and small interfering RNA structure in the RNA interference pathway[J].Cell,2001,107(3):309-321.
5Yang G,Cai KQ,Thompson L,et al.Inhibition of breast and ovarian tumor growth through multiple signaling pathways by using retrovims-mediated small interfering RNA against Her22/neu gene expression[J].J Biol Chem,2004,279(6):4339-4341.
6Martinez LA,Naguibneva I,Lehrmann H,et al.Synthetic small inhibiting RNAs:efficient tools to inactivate oncogenic mutations and restore p53 pathways[J].Proc Natl Acad Sci USA,2002,99(23):14849-14854.
7Steinmetz R,Wagoner HA,Zeng P,et al.Mechanisms regulating the constitutive activation of the ERK signaling pathway in ovarian cancer and the effect of RNA:for ERK1/2 on cancer cell proliferation[J].Mol Endocrinol,2004,15(3):1004-1012.
8Sanceu J,Truchet SB.Matrix metalloproteinase-9 Silenciny by RNA intereference triggers the miagratory-adhesive switch in ewing sarcoma cells[J].Biol Chem,2003,278(38):36537-36546.
9Lakka SS,Gondi CS,Yanamandra N,et al.Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invation,turn growth and angiogenesis[J].Oncogene,2004,23(27):4681-4689.
10Saga Y,Ohwada M,Suzuki M,et al.Glutathione peroxidase 3 is a candidate mechanism of anticancer drug resistance of ovarian clear cell adenocarcinoma[J].Orcol Rep,2008,20(6):1223-1229.
